Efficacy of PegIntron and Rebetol in Previously Untreated Patients With Chronic Hepatitis C Infected With HCV Genotype 1/4/5/6 (Study P04243)

NCT00709059 · clinicaltrials.gov ↗

COMPLETED

Status

538

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

BIOLOGICAL: PegIntron (peginterferon alfa-2b; SCH 54031)
DRUG: Rebetol (ribavirin; SCH 18908)

Sponsor

Merck Sharp & Dohme LLC